Major Growth Driver Identified in 2025 Intravenous Fluid Transfer Drug Devices Market: Rising Hospitalization Rates Driving Growth In Intravenous Fluid Transfer Drug Device Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Intravenous Fluid Transfer Drug Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for drug devices that facilitate the transfer of fluids intravenously has experienced a significant expansion in the recent past. The market, which was worth $7.38 billion in 2024, is projected to rise to $7.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include a heightened demand for efficient medical supplies, expansion of healthcare infrastructure, an increase in surgical procedures necessitating IV support, changes in policy, reinforcement of healthcare structure, and a surge in new drugs that require precise administration.

Intravenous Fluid Transfer Drug Devices Market Size Forecast: What's the Projected Valuation by 2029?
The market size for intravenous fluid transfer drug devices is anticipated to witness significant growth in the upcoming years. Its value is predicted to reach $9.96 billion by 2029, increasing at a Compound Annual Growth Rate of 6.1%. Factors such as the escalating demand for portable devices, amplified expenditure on advanced medical devices, a surge in the requirement for affordable healthcare solutions, and proliferation of non-hospital treatment environments account for this growth in the prediction period. Key trends for the forecast period encompass the implementation of intelligent technologies, adoption of automated systems for IV fluid transfer, improvements in safety attributes to minimize medication mistakes, and the utilization of devices that are compatible with remote monitoring solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

What Are the Drivers Transforming the Intravenous Fluid Transfer Drug Devices Market?
Expectations are high for the intravenous fluid transfer drug device market to expand due to the increasing rate of hospitalizations. Factors such as an aging populace, persistent ailments, sophisticated diagnostic tools, improved healthcare access, lifestyle-related diseases, and advancements in medical technology are contributing to this growth. Fluid transfer systems play a critical role in accurately regulating the administration of fluids and medications directly into a patient's bloodstream while they're in hospital care. For example, a report released by the American Hospital Association (AHA) in May 2023 noted that the total admission numbers in all American hospitals had risen to 34,011,386, a significant increase from 33,356,853 in 2022. Thus, the continuous rise in hospital admissions is set to catalyze the growth of the intravenous fluid transfer drug device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

What Long-Term Trends Will Define the Future of the Intravenous Fluid Transfer Drug Devices Market?
Top players in the intravenous fluid transfer drug device market are innovating to create modular, holistic infusion systems, packed with features such as auto-identification to augment precision, amplify patient security and bolster the delivery of fluids and medications. Auto-identification integrated into these infusion systems checks and pairs the correct medication with the right patient using either barcode scans or RFID technology. To illustrate, Becton, Dickinson, and Company, a medical device firm from the US, gained FDA 510(k) approval in July 2023 for its revamped BD Alaris Infusion System. This system comes with upgraded hardware for its Point-of-Care Unit (PCU), consisting of large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitors and modules for auto-identification. It also features advanced software updates incorporating enhanced cybersecurity and interoperability capabilities, enabling flawless integration with commonly used electronic medical record (EMR) systems. The system is geared towards supporting smart, connected healthcare.

Which Segments in the Intravenous Fluid Transfer Drug Devices Market Offer the Most Profit Potential?
The intravenous fluid transfer drug devicesmarket covered in this report is segmented -

1) By Type: Infusion Bags, Infusion Devices, Other Types
2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications
3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:
1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags
2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices
3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

Which Firms Dominate the Intravenous Fluid Transfer Drug Devices Market by Market Share and Revenue in 2025?
Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

Which Regions Offer the Highest Growth Potential in the Intravenous Fluid Transfer Drug Devices Market?
North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.